Analytical or clinical derivatives, tagged derivatives and metho

Drug – bio-affecting and body treating compositions – Radionuclide or intended radionuclide containing; adjuvant... – Molecular bilayer structure

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

260112R, 2602395, 260291, 424 12, A61K 4300, G01N 3300

Patent

active

041155394

ABSTRACT:
Novel isocyanates such as, for example, blocked L-tyrosine methyl ester isocyanate, are reacted with compounds of biological, clinical interest or the like such as, for example, digoxin, to form derivatives receptive to tagging, as by radiolabeling. The tagged derivatives may then be employed to determine the presence of the compound of interest in nanomolar or even picomolar amounts by using clinical analysis techniques such as radioimmunoassay.

REFERENCES:
patent: 3843696 (1974-10-01), Wagner et al.
patent: 3867366 (1975-02-01), Rubenstein et al.
patent: 3878187 (1975-04-01), Schneider et al.
patent: 3888866 (1975-06-01), Leute et al.
patent: 3953431 (1976-04-01), Rutner et al.
patent: 3996344 (1976-12-01), Gross

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Analytical or clinical derivatives, tagged derivatives and metho does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Analytical or clinical derivatives, tagged derivatives and metho, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Analytical or clinical derivatives, tagged derivatives and metho will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-2120012

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.